9 records – page 1 of 1.

Select Title Policy Type Year
EspAddText
EspRemoveText
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use Policy endorsement 2021
EspAddText
EspRemoveText
Regulation of Self-Care Products in Canada Response to consultation 2016
EspAddText
EspRemoveText
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada Parliamentary submission 2016
EspAddText
EspRemoveText
Legalization, regulation and restriction of access to marijuana Response to consultation 2016
EspAddText
EspRemoveText
Health Canada’s Consultation on “Plain and Standardized Packaging” Response to consultation 2016
EspAddText
EspRemoveText
National pharmacare in Canada: Getting there from here Parliamentary submission 2016
EspAddText
EspRemoveText
Consultation on the prescription drug list: Naloxone Response to consultation 2016
EspAddText
EspRemoveText
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions. Response to consultation 2016
EspAddText
EspRemoveText
Insite: CMA submission regarding Insite supervised injection site and program. Court submission 2011

9 records – page 1 of 1.